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Abstract
A novel dual electrochemical immunosensor for the multiplexed determination of adrenocorticotropin (ACTH) and
cortisol is reported. Aminophenylboronic acid-modified dual screen-printed carbon electrodes were prepared on
which the corresponding ACTH and cortisol antibodies were immobilized. Competitive immunoassays involved bio-
tinylated ACTH and alkaline phosphatase labelled streptavidin, or alkaline phosphatase labelled cortisol. Differen-
tial pulse voltammetry upon 1-naphtyl phosphate addition was employed to monitor the affinity reactions. The
ranges of linearity were 5.0105–0.1 and 0.1–500 ng/mL for ACTH and cortisol. The usefulness of the dual immu-
nosensor was demonstrated by analyzing certified human serum samples with good recoveries.
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1 Introduction
Cortisol (hydrocortisone) is a glucocorticoid produced by
the adrenal gland in response to stress and a low level of
glucocorticoids in blood. Glucocorticoids play an essential
role in the catabolism of peripheral fat, carbohydrates
and proteins. In addition, cortisol has anti-inflammatory
and immune modulatory effects. The secretion of cortisol
is related to that of adrenocorticotropin hormone
(ACTH) through corticotropin-releasing hormone
(CRH). CRH is synthesized and secreted by the hipotha-
lamus. It stimulates pituitary corticotrophic cells to pro-
duce ACTH, a 39-amino acid peptide, which is a fragment
of the larger molecule proopiomelanocortin (POMC).
ACTH promotes growth and hormone synthesis by the
adrenal cortex, and stimulates secretion of glucocorti-
coids, mineralocorticoids and androgenic steroids [1]. As
indicated in the scheme depicted in Figure 1 [2], the
amount of cortisol secreted by the adrenal gland produces
an inhibitory effect on both the synthesis and secretion of
CRH and ACTH through a negative feedback loop to the
hypothalamus and pituitary glands, respectively. Serum
levels of ACTH fluctuate with larger peaks in the early
morning and nadiring in the late afternoon or early eve-
ning, which results in a parallel diurnal rhythm of cortisol
secretion, with peak serum levels in the morning and
lower levels in the evening. Stress, pain, trauma, hypoxia,
hypothermia and hypoglycemia can increase the serum
levels of ACTH. Perturbations of the hypothalamus-pitui-
tary adrenal axis result in different clinical forms of hy-
percorticosolism, including Cushings disease (pituitary
adenoma), ectopic ACTH, ectopic CRH, and primary
adrenal causes [3]. The diagnosis of Cushings syndrome
remains nowadays as one of the most challenging prob-
lems in clinical endocrinology [4]. Among other causes,
this is because clinical manifestations may overlap with
many common clinical conditions. For example, studies
have shown that 2–3% of patients with poorly controlled
type 2 diabetes mellitus have unrecognised Cushings syn-
drome [5]. This diagnosis requires biochemical confirma-
tion of excess cortisol excretion and ACTH determination
in order to classify patients with endogenous hypercorti-
solemia into ACTH independent and dependent [6]. Dif-
ferent levels of ACTH and cortisol concentrations can be
found in serum or urine depending on the type of disease.
Typically, ACTH is decreased in adrenal-dependent Cush-
ings syndrome and maintained/elevated in Cushings dis-
ease [7]. As an example, ACTH levels are undetectable
or low (<5 pg/mL) and cortisol levels are high (>15 mg/
dL) in patients with primary adrenal tumours or hyper-
plasia, whereas patients with corticotropin-dependent
Cushings syndrome have high plasma ACTH levels (>15
pg/mL). Therefore, the development of analytical meth-
ods able to provide multiplexed determination of ACTH
and cortisol hormones should help to perform a faster
classification of the patients as well as an easier diagnosis
of this kind of diseases. Nevertheless, these methodolo-
gies require to be sufficiently sensitive, robust and selec-
tive [8].
Radioimmunoassays and immunochemiluminiscence
assays are the most often used methodologies for clinical
determination of cortisol and ACTH independently [4,7].
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However, in some cases, the assays are not sensitive
enough to determine the low concentrations of ACTH in-
volved in ACTH-independent Cushings syndrome [7].
Because of their high sensitivity, rapid response and us-
ability, electrochemical immunosensors have demonstrat-
ed to be excellent alternatives in clinical analysis of se-
lected analytes [9,10]. Our group has developed recently
electrochemical immunosensors for the determination of
some hormones. For example, testosterone was deter-
mined in serum using configurations based on the immo-
bilization of anti-testosterone antibodies on gold nanopar-
ticles-carbon nanotubes-Teflon composite electrodes [11].
Magnetic electrochemical immunosensors were also de-
veloped for testosterone [12], prolactin [13] and cortisol
[14]. Moreover, the ultrasensitive detection of ACTH was
accomplished by using disposable phenylboronic-modified
electrochemical immunosensors [15].
In this paper, we report the preparation of a dual elec-
trochemical immunosensor for the multiplexed determi-
nation of ACTH and cortisol, which satisfies the require-
ments of sensitivity, selectivity and reproducibility needed
for clinical applications. Aminophenylboronic acid-modi-
fied electrodes were prepared on which the correspond-
ing ACTH and cortisol antibodies were immobilized.
Competitive immunoassays were then performed and dif-
ferential pulse voltammetry upon 1-naphtyl phosphate
addition was employed to monitor the affinity reactions.
The usefulness of the approach was demonstrated by its
application to serum samples.
2 Experimental
2.1 Apparatus and Electrodes
Electrochemical measurements were carried out using an
1030 B Electrochemical Analyzer from CH Instruments.
Dual screen-printed electrodes (C 1110 DropSens,
Oviedo, Spain) consisted of two elliptic carbon working
electrodes, a carbon counter electrode and a silver
pseudo-reference electrode. All experiments were per-
formed at room temperature. A P-Selecta ultrasonic bath,
and a P-Selecta Agimatic magnetic stirrer, all distributed
by Scharlab, Madrid, Spain, were also used.
2.2 Reagents and Solutions
Anti-ACTH C-terminal was purchased from Fitzgerald
MA, USA. 1.05 mg/mL solutions were prepared in phos-
phate buffer solution of pH 7.4 (PBS). Diluted solutions
of both ACTH (Genway Biotech, CA, USA) and biotiny-
lated ACTH (Biotin-ACTH) (AnaSpec, CA, USA) were
prepared in PBS. Murine monoclonal anti-cortisol was
from East Coast Bio, ME, USA. 2.39 mg/mL solutions
were prepared in PBS. Cortisol labelled with alkaline
phosphatase in position 3 (cortisol-AP), with an enzyme
activity of 1840 U/mg, was obtained from Cal Biore-
agents, CA, USA. Diluted solutions were prepared daily
in Tris buffer solution of pH 7.2 which also contained 2%
BSA. A 500 mg/mL stock solution of unlabelled cortisol
(Aldrich >98%) in methanol was prepared. More diluted
solutions were prepared in Tris buffer solution of pH 7.2.
A 50 mM Tris (Scharlau, 99%) and 20 mM NaCl (Schar-
lau, 99%) buffer solution of pH 7.2, and a 0.1 M Trizma
base (Sigma, 99%) and 1 mM magnesium chloride (Pan-
reac, 99%) buffer solution of pH 9.0, were employed. 1-
Naphthyl phosphate monosodium salt monohydrate (1-
NPP, Sigma) was also used. 0.05 M 1-NPP solutions were
prepared daily in Trizma base buffer of pH 9.0. BSA
(Gerbu, tipo VH) was also used. 2% BSA solutions in
both PBS and Tris buffer solution of pH 7.2 were used.
Streptavidin labelled with alkaline phosphatase (Strept-
AP) (Sigma) was also employed. Diluted solutions were
prepared in Tris buffer solution of pH 7.2. 4-Aminobenzo-
ic acid (ABA, Across), 4-amino phenyl boronic acid
(APBA, Sigma), 1-ethyl-3-[3-dimethylaminopropyl] car-
bodiimide hydro-chloride (EDC) (Sigma) and N-hydroxy-
succinimide (NHS) (Sigma) were also used.
2.3 Samples
Samples containing different ACTH and cortisol mixtures
were analyzed. These were prepared from certified
lyophilised human sera containing 10 mg/mL ACTH
(NIBSC, 74/555) or 277 ng/mL cortisol (European Refer-
ence Materials, ERM-DA 193, Sigma), in the reconstitut-
ed serum, respectively.
2.4 Procedures
2.4.1 Modification of Dual SPC Electrodes
Figure 2a displays a scheme of the employed procedure.
Firstly, 20 mg of 4-aminobenzoic acid were dissolved in
2 mL 1 M HCl and cooled with ice. Then, the correspond-
ing diazonium salt was prepared by adding dropwise
a 2 mM NaNO2 aqueous solution (38 mL for each 200 mL
of 4-aminobenzoic acid solution) with constant stirring.
Next, 40 mL of the resulting solution were spotted onto
Fig. 1. Diagram illustrating the hypothalamus, pituitary and
adrenal axis, and the stimulating or negative feedback from
CRH, POMC, ACTH and cortisol. Modified from [2].
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the SPC electrodes and ten successive voltammetric
cycles from 0.0 to 1.0 V (v=200 mV/s) were scanned.
Finally, the modified electrodes were washed thoroughly
with water and methanol, and dried at room temperature.
In a second step, 10 mL of an EDC/NHS mixture (0.1 M
each) aqueous solution were spotted onto the modified
electrodes and left to react for 1 h. After rinsing with
water and methanol and allowing drying, 10 mL of
a 50 mM 3-aminophenylboronic acid were placed onto
the electrodes. After 3 h incubation, the resulting amino-
phenylboronic acid-modified electrodes (APBA/SPCEs)
were thoroughly rinsed with water and methanol and al-
lowing drying at room temperature.
2.4.2 Preparation of the Immunosensors
ACTH and cortisol immunosensors were prepared on
APBA/SPCE1 and APBA/SPCE2 modified electrodes,
respectively. 4 mL of 30 mg/mL anti-ACTH and 50 mg/mL
anti-cortisol solutions in PBS were dropped onto the re-
spective electrode and left stand overnight at 8 8C. Then,
4 mL of a 2% BSA blocking solution were deposited onto
both electrodes and incubation was allowed for 1h at
room temperature. Competitive immunoassays were per-
formed by spotting 4 mL of a mixture solution of ACTH
(or the sample) and 1 mg/mL biotinylated-ACTH (biotin-
ACTH) on the anti-ACTH/APBA/SPCE1 electrode, and
4 mL of a mixture solution of cortisol (or the sample) and
1 mg/mL alkaline phosphatase-labelled cortisol 2% BSA
(AP-cortisol) on the anti-cortisol/APBA/SPCE2 electrode
allowing incubation at both electrodes for 45 min at 8 8C.
Thereafter, 4 mL of 2 mg/mL alkaline phosphatase-labelled
streptavidin (Strept-AP) and 4 mL of Tris buffer solution
of pH 7.2 were added to the Biotin-ACTH/anti-ACTH/
APBA/SPCE1 and the cortisol-AP/anti-cortisol/APBA/
SPCE2, respectively. After 60 min incubation at 8 8C,
45 mL Trizma buffer plus 5 mL of 0.05 M 1-NPP solution
were deposited onto the electrodes and allowed to stand
for 8 minutes. Differential pulse voltammograms were re-
corded over the 0.15 to +0.60 V range to obtain the
electroanalytical signals.
2.4.3 Multiplexed Determination of ACTH and Cortisol in
Serum
Lyophilised human sera containing ACTH or cortisol
were reconstituted, respectively, in 2.5 mL or 1.25 mL
Milli-Q water to obtain 10 mg/mL ACTH, or 277 ng/mL
cortisol stock solutions. From these stock solutions, differ-
ent ACTH-cortisol mixtures also containing Biotin-
ACTH or cortisol-AP conjugates were prepared and spot-
ted on the anti-ACTH/APBA/SPCE1 anti-cortisol/
Fig. 2. Schematic picture for the preparation of the dual electrochemical immunosensor for multiplexed determination of ACTH and
cortisol.
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APBA/SPCE2 electrodes. Thereafter, the ACTH and cor-
tisol were simultaneously determined by applying the
procedure described above which involved simultaneous
measurement of the respective DPV peak current values
at each electrode and interpolation into the linear portion
of the corresponding calibration plot obtained with
ACTH or cortisol standard solutions.
3 Results and Discussion
The methodologies employed in the design and function-
ing of the dual immunosensor are illustrated in Figure 2.
As it is described in Section 2.4.1, firstly, SPCE1 and
SPCE2 were modified with boronic acid as described in
the Experimental section (Procedure 2.4.1.). Subsequent-
ly, anti-ACTH and anti-cortisol antibodies were attached
to the resulting APBA/SPCEs through the oriented bor-
onic acid-saccharide bonds [16]. After a blocking step
with BSA, competitive assays between ACTH and
Biotin-ACTH, and between cortisol and cortisol-AP for
the binding sites of the respective antibodies were accom-
plished. In the case of the ACTH immunosensor a further
conjugation with streptavidin labelled with alkaline phos-
phatase was carried out. In both cases, 1-NPP was em-
ployed as AP substrate to detect the immunosensing
events and the electrochemical oxidation of the generated
enzyme reaction product, 1-naphtol, was measured by dif-
ferential pulse voltammetry. Cyclic voltammetry from
a 5 mM [Fe(CN)6]3/4 0.1 M KCl solution was employed
to characterize the modified electrode surface of SPCE1
and SPCE2 upon the different modification steps
(Figure 3). As expected, voltammograms 1 to 4 were simi-
lar at both electrodes.
Modification of SPCEs with ABA produced a sharp de-
crease in the voltammetric response due to the electro-
static repulsion between the redox probe and the nega-
tively charged carboxylate groups. Upon activation of the
surface-confined carboxyl groups with EDC/NHS and at-
tachment of APBA moieties to the electrode surface
through the formation of amide bonds (voltammograms 3
and 4), an increase in the voltammetric response to the
redox probe was observed as a consequence of the elec-
trode negative surface charge neutralization. Conversely,
the peak current measured at the anti-ACTH/APBA/
SPCE1 (curve 5) was remarkably higher than that ob-
tained with the anti-cortisol/APBA/SPCE2 (curve 5’),
thus reflecting differences in the antibodies loadings and
characteristics.
3.1 Optimization of the Experimental Variables Involved
in the Immunosensors Responses
All variables involved in the electroanalytical responses
of the dual immunosensor for ACTH and cortisol were
optimized. Firstly, the respective antibody loadings into
the APBA/SPCE1 and APBA/SPCE2 were evaluated by
checking the DP voltammetric responses obtained with
different immunosensors prepared with no ACTH or cor-
tisol and by spotting 4 mL of anti-ACTH or anti-cortisol
solutions prepared in the 0 to 80 mg/mL antibody concen-
tration range, respectively. 1 mg/mL Biotin-ACTH M 1-
NPP were used in these experiments. Figure 4a shows as
the measured ip values increased both at the ACTH and
cortisol immunosensors with the antibody loading, exhib-
iting a remarkably lower increase from 30 mg/mL anti-
ACTH and 50 mg/mL anti-cortisol. Therefore, these anti-
bodies loading values were selected for further work. Fur-
thermore, anti-ACTH/APBA/SPCE1 and anti-cortisol/
APBA/SPCE2 were allowed to stay overnight at 8 8C.
In order to reduce non-specific binding of immunore-
agents on the electrodes surfaces, a blocking step with
BSA was accomplished. In a first approach, the experi-
mental conditions optimized previously for ACTH (2%
BSA and 1h incubation time) [15] were used. Although
the unspecific responses from Strept-AP at SPCE were
found to be always lower than 10% of the signals ob-
tained with the Strept-AP/Biotin-ACTH/anti-ACTH/
APBA/SPCE, the nonspecific binding was remarkably
higher when cortisol-AP was involved. Figure 5 displays
Fig. 3. Cyclic voltammograms recorded for a 5 mM [Fe(CN)6]
3/4 0.1 M KCl solution at (1) bare SPCE; (2) ABA/SPCE; (3) activat-
ed ABA/SPCE; (4) APBA/SPCE; (5) anti-ACTH/APBA/SPCE; (5’) anti-cortisol/APBA/SPCE; v=100 mV/s.
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DP voltammograms recorded at SPCEs from cortisol-AP
solutions without blocking with BSA (curve 1) and with
a blocking step with 2% BSA for different incubation
times (curves 2 and 3). The DP voltammograms recorded
upon spotting a cortisol-AP-2% BSA mixture solution
with and without a further incubation step with 2% BSA
are also displayed (curves 4 and 5). As it can be observed,
the lower unspecific signal was obtained when the corti-
sol-AP solution was prepared in the presence of 2%
BSA, and the electrode was also blocked with 2% BSA
during 1 h incubation time. Using these experimental con-
ditions, Figure 5b compares the differential pulse voltam-
mograms obtained in the measurement of the specific re-
sponse of the cortisol-AP/anti-cortisol/APBA/SPCE im-
munosensor for 0 ng/mL cortisol (curve 1) and 250 ng/mL
cortisol (curve 2), with the unspecific voltammetric signal
(curve 3). As it can be seen, a large analytical signal-to-
background current ration could be obtained thus allow-
ing the sensitive determination of cortisol to be per-
formed with the dual immunosensor.
The concentration of Biotin-ACTH was optimized by
preparing various Strept-AP/Biotin-ACTH/anti-ACTH/
APBA/SPCE immunosensors which were incubated in
Biotin-ACTH solutions with different concentrations
ranging between 0 and 2 mg/mL. Figure 4b shows as the
DP peak current measured for 0 ng/mL ACTH exhibited
a rapid increase from 0 to 0.75 mg/mL and levelled off for
higher Biotin-ACTH concentrations. Accordingly, 1 mg/
mL Biotin-ACTH concentration was selected for further
work. Moreover, 45 min at 8 8C was the optimized value
for incubation of the anti-ACTH/APBA/SPCE immuno-
sensors with the Biotin-ACTH solution (results not
shown).
As it was illustrated in Figure 1, Strept-AP was used as
the labelled protein in the immunosensor design to deter-
mine ACTH. The conjugate concentration was optimized
by testing the voltammetric response of different immu-
nosensors incubated with Strept-AP in the 0 to 3 mg/mL
range. The obtained results (Figure 4c) revealed a rapid
current increase up to 2 mg/mL Strept-AP and a practically
constant value for larger conjugate concentrations. There-
fore, that concentration, which probably corresponded to
the saturation of the biotinylated ACTH, was selected for
further work. Moreover, optimal results were achieved
when the incubation step with the Strept-AP solution was
performed at 8 8C for 60 minutes (results not shown).
Similarly, the cortisol-AP concentration was optimized
in the case of the cortisol immunosensor preparation.
Fig. 4. Optimization of the different experimental variables involved in the preparation of the dual immunosensor for ACTH and
cortisol.
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This was made by checking the DP voltammetric re-
sponse of various immunosensors incubated with the con-
jugate in the 0 to 2 mg/mL concentration range. Figure 4d
shows a rapid increase in the ip value with the conjugate
concentration at the lower cortisol-AP concentration
values reaching a constant response from 1 mg/L, indicat-
ing saturation of the antibodies binding sites. Using this
conjugate concentration, an incubation time of 45 min at
8 8C resulted appropriate to allow an adequate competi-
tion between cortisol and cortisol-AP for the binding po-
sitions of anti-cortisol.
As it was mentioned already, 1-NPP was the alkaline
phosphatase substrate employed to generate the enzymat-
ic product suitable to be voltammetrically detected at the
modified electrodes surface for both immunosensors [14].
Thus, the influence of 1-NPP concentration on the simul-
taneous differential pulse voltammetric responses of both
the Strept-AP/Biotin-ACTH/anti-ACTH/APBA/SPCE1
and cortisol-AP/anti-cortisol/APBA/SPCE2 immunosen-
sors was evaluated in the 5106 to 0.1 M range (results
not shown). The highest peak current values were ach-
ieved using a 50 mM 1-NPP concentration, which repre-
sented a relatively high value suitable to ensure that the
enzyme reaction rate depended only on the enzyme con-
centration. Finally, 8 min was selected as an optimal hy-
drolysis time of the enzyme substrate. The possible cross-
talk between the two SPCEs and reaction products was
evaluated by recording DP voltammograms at the immu-
nosensors where mixture solutions of ACTH and cortisol
were deposited. Figure 6 compares the voltammograms
recorded from 50 ng/mL ACTH plus 1 mg/mL cortisol-AP
(curve 1) and only 1 mg/mL cortisol-AP (curve 2) at the
cortisol-AP/anti-cortisol/APBA/SPCE2. Similarly, voltam-
mograms recorded with the Strept-AP/Biotin-ACTH/anti-
ACTH/APBA/SPCE1 for both 500 ng/mL cortisol plus
1 mg/mL Biotin-ACTH (curve 3) and only 1 mg/mL
Biotin-ACTH (curve 4) are also displayed in Figure 6. As
it can be observed, no significant differences in the vol-
tammetric responses with each immunosensor were found
in the presence and in the absence of the non-target ana-
lyte, thus demonstrating that no appreciable cross-talking
occurred with the developed dual immunosensor.
3.2 Analytical Characteristics for ACTH and Cortisol
Determination with the Dual Immunosensor
Figure 7 shows the calibration plots for ACTH and corti-
sol obtained by differential pulse voltammetry under the
optimized conditions stated above. The concentrations of
ACTH and cortisol were measured between the 5108–
0.1 and 5104–5103 ng/mL ranges, respectively. The
corresponding analytical characteristics are summarized
Fig. 5. a) Unspecific DPV responses from 1 mg/mL cortisol-AP at SPCEs (1); 1 mg/mL cortisol-AP and 1 h incubation in 2% BSA
(2); 1 mg/mL cortisol-AP and 2 h incubation in 2% BSA (3); 1 mg/mL cortisol-AP+2% BSA (4); 1 mg/mL cortisol-AP+2% BSA and
1 h incubation in 2% BSA (5); 0.05 M 1-NPP; b) Specific (1), competitive (2) and unspecific DPV responses obtained with an anti-
cortisol/APBA/SPCE immunosensor for 0 ng/mL (1) and 250 ng/mL (2) cortisol; the unspecific response (3) was measured as in a)
(5). 50 mg/mL anti-cortisol; 1 mg/mL cortisol-AP; 0.05 M 1-NPP.
Fig. 6. DPVresponses from: cortisol-AP+ACTH/anti-cortisol/
APBA/SPCE2 (curve 1 - - - -); cortisol-AP/anti-cortisol/APBA/
SPCE2 (curve 2 —); Strept-AP/Biotin-ACTH+cortisol/anti-
ACTH/APBA/SPCE1 (curve 3 - - - -); Strept-AP/Biotin-ACTH/
anti-ACTH/APBA/SPCE1 (curve 4 —).
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in Table 1. The ip vs. concentration curves were fitted by
non-linear regression using the Sigma Plot data analysis
software. The adjusted equation was:
ip ¼
imax  imin
1þ EC50=xþ imin
with r=0.998 (ACTH) and r=0.999 (cortisol), where imax
and imin were the maximum and minimum current values
of the calibration graphs: 2.920.07 and 0.093
0.006 mA, respectively, for ACTH, and 6.640.01 and
0.0380.008 mA, respectively, for cortisol. As can be seen
in Table 1, both calibration graphs provided wide linear
concentration ranges, this being in agreement with the
low Hill slope values [17]. The limits of detection were
calculated from the equation [18]:
LOD ¼ EC50ð
imax  imin
imax  imin  3s 1Þ
1=h
where s is the standard deviation (n=10) of the zero
value (the ip value measured in the absence of ACTH or
cortisol). This value was 0.24 mA for ACTH and
0.12 mA for cortisol, with relative standard deviations of
6.3% (n=5) for both compounds. Accordingly, LOD
values of 40 pg/L ACTH and 37 pg/mL cortisol were ach-
ieved. These analytical characteristics are much better
than those reported previously in the literature for the in-
dividual determination of ACTH or cortisol using other
approaches and similar to those reported recently by our
group. In fact, various immunoassays were proposed for
the determination of ACTH based on different antibodies
and using radioactivity, chemiluminiscence or fluores-
cence as detection techniques. These methodologies al-
lowed ranges between a few units up to various hundreds
of ng/L ACTH to be covered [19–21], concentrations that
are much larger than those appearing in the linear range
obtained for this hormone with the developed Strept-AP/
Biotin-ACTH/anti-ACTH/APBA/SPCE1 immunosensor.
On the other hand, the electrochemical immunosensor
for ACTH previously described by our group provided
a detection limit of 18 pg/L [15]. This slight difference is
most likely due to the remarkably smaller surface area of
the SPCE working electrodes in the dual device
(5.6 mm2) with respect to that of the single SPCE used
for the individual determination of ACTH (12.56 mm2).
Fig. 7. Calibration plots for ACTH (*) and cortisol (*) obtained with the Strept-AP/Biotin-ACTH/anti-ACTH/APBA/SPCE1 and
cortisol-AP/anti-cortisol/APBA/SPCE2 immunosensors.
Table 1. Analytical characteristics of the multiple electrochemical immunosensor for the simultaneous determination of ACTH and
cortisol.
Analyte Linear range (ng/mL) r EC50 (ng/mL) Hill slope LOD (pg/mL)
ACTH 5.0103–0.1 0.991 0.00070.0002 0.370.03 0.04
Cortisol 0.1–500 0.996 122 0.500.03 37
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Regarding cortisol, the limit of detection achieved in this
work with the cortisol-AP/anti-cortisol/APBA/SPCE2 im-
munosensor was one half of the smallest reported value
(72 pg/mL) obtained by a non-competitive colorimetric
ELISA using cortisol-poly(l-lys) conjugates and HRP-
cortisol [22]. Comparing with a previous immunosensor
reported by our group using SPCEs and protein-A func-
tionalized magnetic microparticles [14], the limit of detec-
tion is approximately ten times higher but the range of
linearity is wider. This difference is due not only to the
smaller electrochemical surface area of SPCE2 compared
with the conventional SPCEs used in [14], but also to the
ability of magnetic microparticles to immobilize a high
concentration of biomolecules onto the electrode surface
allowing the achievement of high sensitivities.
It is important to remark that the limits of detection
achieved for both analytes with the dual immunosensor
fulfils the requirements for the analysis of the hormones
in human serum considering that in typical diseases the
ACTH and cortisol concentrations are around 0.005 ng/
mL and 150 ng/mL, respectively.
The reproducibility of the DP voltammetric measure-
ments was evaluated by carrying out repetitive assays in
the same day and in different days for solutions contain-
ing no ACTH or cortisol and for 1 pg/mL ACTH or
10 ng/mL cortisol (concentrations similar to the respec-
tive EC50 values). Relative standard deviation (RSD)
values of 6.3% (n=8) were obtained for the assays per-
formed on the same day with both ACTH and cortisol
immunosensors, whereas the RSD values (n=8) were
7.6% when no ACTH was present and 8.5% for 1 pg/mL
ACTH, and 7.9% without cortisol and 8.1% for 10 ng/
mL cortisol, when the measurements were carried out on
different days. The storage stability of the anti-ACTH/
APBA/SPCE1, Strept-AP/Biotin-ACTH/anti-ACTH/
APBA/SPCE1, anti-cortisol/APBA/SPCE2 and cortisol-
AP/anti-cortisol/APBA/SPCE2 immunosensors was also
evaluated. In order to do that, different bioelectrodes
were prepared on the same day and stored in a refrigera-
tor at 4 8C. Then, each bioelectrode was used to construct
the corresponding immunosensor and to measure the vol-
tammetric response for 5 mM 1-NPP in the absence of
ACTH or cortisol. As an example, Figure 8 shows the
control chart displaying the results obtained for a period
of time of 21 days for anti – ACTH/APBA/SPCE1 (*)
and anti-cortisol/APBA/SPCE2 (*) immunosensors. Each
point in the control chart represented the mean value of
three successive measurements and the control limits
were set at 3 times the standard deviation calculated
for the whole series of experiments. As it can be seen,
both bioelectrodes yielded voltammetric responses that
remained inside the control limits for 15 days. On the
other hand, the storage stability of the bioelectrodes con-
structed with all the bioconjugates, Strept-AP/Biotin-
ACTH/anti-ACTH/APBA/SPCE1 and cortisol-AP/anti-
cortisol/APBA/SPCE2 was much poorer retaining only
approximately 30% of the initial value after twelve days
from their preparation.
3.3 Simultaneous Determination of ACTH and Cortisol
in Certified Human Sera
The usefulness of the dual immunosensor for the multi-
plexed analysis of real samples was evaluated by analyz-
ing certified human serum samples. Calibration graphs
for ACTH and cortisol were constructed from the recon-
stituted serum by appropriate dilution with the respective
working buffer solutions in the 0.01 to 100 pg/mL ACTH
and 0.1 to 200 ng/mL cortisol concentration ranges. It was
observed that the calibration graphs constructed in dilut-
ed sera fifted perfectly with the calibration graphs ob-
tained with standard solutions of the analytes depicted in
Figure 6. Actually, the linear ranges of the calibration
plots recorded with the serum samples exhibited slope
values of 0.5070.006 mA (r=0.999) for ACTH, and
1.60.1 mA (r=0.998) for cortisol, which were very
similar to those obtained for ACTH and cortisol standard
solutions (0.510 mA and 1.59 mA). These results, show-
ing that no significant matrix effect existed, allowed the
simultaneous determination of ACTH and cortisol to be
performed by interpolation of the measured ip values
into the calibration plots constructed with ACTH and cor-
tisol standard solutions. The results obtained in the analy-
ses carried out at four different concentration levels for
each hormone in the samples are summarized in Table 2.
As it can be seen, recoveries ranged between 98.30.1
and 1023% for ACTH and 999 and 1048% for
cortisol. These results demonstrated fairly well the useful-
ness of the developed dual immunosensor for the multi-
plexed analysis of low ACTH and cortisol concentrations
in human sera with practically no sample treatment.
4 Conclusions
In this paper, the development of an electrochemical mul-
tiple-analyte immunosensor for the ultrasensitive multi-
plexed determination of ACTH and cortisol hormones in
Fig. 8. Control chart constructed for anti-ACTH/APBA/SPCE1
(*) and anti-cortisol/APBA/SPCE (*). Each point corresponds
to the mean value for three successive measurements of 5 mM 1-
NPP.
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human serum is reported for the first time. The immuno-
sensing approach involves the immobilization of anti-
ACTH or anti-cortisol onto phenylboronic acid-modified
dual screen printed carbon electrodes, competitive immu-
noassay implying biotinylated ACTH and alkaline phos-
phatase labelled streptavidin, or alkaline phosphatase la-
belled cortisol. and differential pulse voltammetric trans-
duction of the affinity reactions. The developed dual im-
munosensor exhibits excellent analytical performance in
terms of sensitivity, selectivity, wide range of quantifiable
antigen concentrations, and inter-assay reproducibility.
Therefore, this multiple-analyte immunosensor can be en-
visaged as a useful and affordable analytical tool for the
rapid determination of ACTH and cortisol in clinical ap-
plications, as it has been outlined with the results ob-
tained for the analysis of certified human serum samples.
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